drospirenone has been researched along with Gall Bladder Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kothari, C; Shah, M | 1 |
| Bressler, B; Brophy, JM; Delaney, JA; Etminan, M | 1 |
| Jick, S; Pennap, D | 1 |
3 other study(ies) available for drospirenone and Gall Bladder Diseases
| Article | Year |
|---|---|
Comparative Safety Assessment Study for Drospirenone Induced Gallbladder Diseases Using the Adverse Drug Reaction Database of USA, Europe, and Canada.
Topics: Adverse Drug Reaction Reporting Systems; Androstenes; Canada; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Gallbladder Diseases; Humans; Pharmacovigilance; United States; United States Food and Drug Administration | 2021 |
Oral contraceptives and the risk of gallbladder disease: a comparative safety study.
Topics: Adult; Androstenes; Cholecystectomy; Confidence Intervals; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Gallbladder Diseases; Humans; Levonorgestrel; Progestins; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors | 2011 |
Drospirenone- and levonorgestrel-containing oral contraceptives and the risk of gallbladder disease.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Cholecystectomy; Cholecystitis; Contraceptives, Oral; Databases, Factual; Female; Gallbladder Diseases; Humans; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Odds Ratio; Risk Factors; United Kingdom | 2012 |